You are here
AstraZeneca slumps on report CEO is heading to Teva
Moving to a generic drugmaker, albeit the world's largest, would be a big change in direction for French-born Mr Soriot, 58.
London
SHARES in AstraZeneca fell more than 5 per cent on Thursday after the company declined to deny a media report that chief executive Pascal Soriot was about to defect to Israel-based Teva Pharmaceutical Industries.
Mr Soriot, who has led the
GAIN ACCESS TO ALL BT PREMIUM CONTENT:
Or get a 2-week FREE trial
Need help?
- CALL +65 6388 3838
- EMAIL btocs@sph.com.sg
